Inamed is an international Contract Research Organization providing its clients with the full range of services, required for the planning, conduct and evaluation of clinical trials throughout all phases, for nearly two decades. Complementing our solid experience in conducting clinical trials in various indications, Inamed's team of inhalation and clinical experts provides our sponsors with a unique spectrum of services. Besides our clinical trial operations and state-of the-art, in-house clinical pharmacology unit with 12 beds (+6 intensive monitoring beds), Inamed performs in-vitro studies in its own labs and is a leading CRO in continental Europe able and approved to perform scintigraphy studies, with radiolabeled compounds, under GMP requirements. Our studies deliver the highest quality data and can enhance your clinical trials and development projects for drugs and inhalation devices. Inamed offers an opportunity for sponsors to get their products to market more successfully.
Ranging from dedicated respiratory clinical trials, such as Phase I-IV with inhaled compounds or inhalation devices, up to specialized clinical trials such as Flow-Profile or scintigraphy lung deposition studies, Inamed provides the full range of services.Read more
At its own in-house Clinical Pharmacology Unit, Inamed is prepared to conduct all kinds of early phase clinical trials, ranging from First-in-Man studies up to studies with complex endpoints.Read more
Today the Journal of Aerosol Medical Pulmonary Drug Delivery published the results of a clinical lung scintigraphy study performed at Inamed. Read more
One of Inamed’s key competencies is the radio-label Aerosols (using 99mTechnetium) for the use in clinical studies. Therefore, Inamed is regularly subject to inspections, executed by the Regional Council of Upper Bavaria and was able to acquire an extension of the manufacturing license during an inspection according to § 64 AMG on November 16 & 17th, 2015. Read more
February 29 - March 3, 2016
Hear our talk on "Clinical First in Man Studies (FIM), Determination of the Bioavailability, Important Interaction Studies" by Dr. Wolfgang Timmer.Read more